Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PI4KA | P42356 | 1/20 | 0.36 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.36 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.36 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | AHCY | P23526 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9851733 | 0.90 | SLC29A1 (0.41) | ADORA3GAAPI4KAPI4K2BPI4K2A | |
| SCHEMBL9851739 | 0.90 | SLC29A1 (0.41) | ADORA3GAAPI4KAPI4K2BPI4K2A | |
| SCHEMBL9851785 | 0.87 | BCHE (0.45) | ADORA3BCHEAHCY | |
| SCHEMBL9851797 | 0.87 | BCHE (0.45) | ADORA3BCHEAHCY | |
| SCHEMBL9851908 | 0.85 | ADORA1 (0.35) | ADORA3GAAPI4KAPI4K2BPI4K2A | |
| SCHEMBL9851844 | 0.81 | ADORA3 (0.35) | ADORA3GAAADORA1AHCY | |
| SCHEMBL9851766 | 0.80 | SLC29A1 (0.39) | ADORA3GAAPI4KAPI4K2BPI4K2A | |
| SCHEMBL9851773 | 0.80 | SLC29A1 (0.39) | ADORA3GAAPI4KAPI4K2BPI4K2A | |
| SCHEMBL9851720 | 0.80 | ADORA1 (0.36) | ADORA3GAAPI4KAPI4K2BPI4K2A | |
| SCHEMBL7069026 | 0.78 | PRKAB2 (0.46) | ADORA3ADORA1AHCY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0450102-A1 | NUCLEOSIDE DERIVATIVE | Yamasa Shoyu Kabushiki Kaisha (JP) | 1991-10-09 | — | — | EP | disclosed |